The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: undefined vs RMRP
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: undefined CSPEC Genes: [ 'RMRP' ] * Message MONDOs: MONDO:0009595 CSPEC MONDO: [ 'MONDO:0009595' ]
  • No CSPEC computed assertion could be determined for this classification!


Variant: NR_003051.4(RMRP):n.-24_-3dup

CA587570196

1454754 (ClinVar)

Gene: N/A
Condition: cartilage-hair hypoplasia (MONDO:0009595)
Inheritance Mode: Autosomal recessive inheritance
UUID: fa606dac-e859-494e-9d3d-afd5d6b163ed
Approved on: 2025-10-22
Published on: 2025-10-22

HGVS expressions

NR_003051.4:n.-24_-3dup
NR_003051.4(RMRP):n.-24_-3dup
NC_000009.12:g.35658023_35658044dup
CM000671.2:g.35658023_35658044dup
NC_000009.11:g.35658020_35658041dup
CM000671.1:g.35658020_35658041dup
NC_000009.10:g.35648020_35648041dup
NG_017041.1:g.4976_4997dup
NG_033120.1:g.4734_4755dup
More

Pathogenic

Met criteria codes 6
PP1_Moderate PM2_Supporting PM1_Strong PP4 PM3_Strong PM4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RMRP Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The NC_000009.12:g.35658023_35658044dup variant is a 22-base duplication upstream of the transcribed region of the RMRP gene. This variant is also known as NR_003051.4(RMRP):n.-24_-3dup or g.–25_–4dup22TACTACTCTGTGAAGCTGAGAA. It locates between the TATA box (spanning n.-32 to n.-24) and the transcription start site (n.4) (PM1_Strong). It inserts 22 nucleotides that increases the distance between the TATA box and the transcription start site (PM4_Moderate). The Grpmax Filtering allele frequency of this variant is 0.000004890 in gnomAD v4.1.0, which is lower than the SCID-VCEP threshold (<0.0000447) for PM2_Supporting (PM2_Supporting). This variant is reported in trans with the variant g.196C>T (previously curated as pathogenic by the SCID VCEP: NC_000009.12:g.35657823G>A) in four Brazilian patients and is reported in trans with the variant g.97_98dup2(TG) (not curated by the SCID VCEP) in one Brazilian patient (+1.0 points each). The total score is 2.0 meeting this criterion PM3_Strong. (PMID: 32021596). Among these cases, two affected siblings have been described (PP1_Moderate). At least one patient presented with metaphyseal dysplasia (+1.0 points) and hypotrichosis (+0.5 points). PP4 is met. In summary, this variant is classified as pathogenic for Autosomal Recessive Cartilage Hair Hypoplasia based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PM2_Supporting, PM1_Strong, PM4_Moderate, PM3_Strong, PP1_Moderate, PP4 (SCID VCEP specifications version 1).
Met criteria codes
PP1_Moderate
This variant has been reported in two affected siblings in trans with the variant g.196C>T.
PM2_Supporting
The Grpmax Filtering allele frequency of this variant is 0.000004890 in gnomAD v4.1.0, which is lower than the SCID-VCEP threshold (<0.0000447) for PM2_Supporting. PM2_Supporting is met.
PM1_Strong
This variant locates between the TATA box (spanning n.-32 to n.-24) and the transcription start site (n.4) (PM1_Strong).
PP4
At least one patient (patient 2) presented with metaphyseal dysplasia (+1.0 points) and hypotrichosis (+0.5 points). Immunological status for affected patients is not evaluated in this study. Total score is 1.5 points. PP4 is met (PMID: 32021596).
PM3_Strong
This variant is in trans with variant g.196C>T in four Brazilian patients with CHH including two affected siblings (+1.0 points) and in trans with variant g.97_98dup2(TG) in another Brazilian patient with CHH (+1.0 points) (PMID: 32021596), reaching a total of 2.0 points meeting PM3_Strong.
PM4
This variant inserts 22 nucleotides that increases the distance between the TATA box (spanning n.-32 to n.-24) and the transcription start site (n.4) (PM4_Moderate).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.